Found 234 matching trials
Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease PHASE2 CNI-1493-CD05 is an open-label extension study of CNI-1493-CD04. In the CD0...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy N/A A case-control study to evaluate the immunoinflammatory effect of prior exp...
Show More Location
Stanford University
Learn More & Join Trial
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital N/A Prevelance of axial spondylosis arthritis in inflammatory bowel disease and...
Show More Location
Multiple Locations
Learn More & Join Trial
Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy NA This study aims to evaluate a new tool designed to help doctors decide whet...
Show More Location
Complejo Hospitalario Universitario de A Coruña
Learn More & Join Trial
Treating the Resistant Patent Ductus Arteriosus (PDA) PHASE2 Persistent postnatal ductal patency may have significant adverse hemodynami...
Show More Location
Neonatal Intensive Care Unit - Shaare Zedek Medical Center
Learn More & Join Trial
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success N/A The primary goal of the study is to develop an early (within 4 weeks) combi...
Show More Location
University Hospital Bern Inselspital
Learn More & Join Trial
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease PHASE3 The purpose of this study was to determine how effective and safe the study...
Show More Location
Arizona Arthritis & Rheumatology Associates, P.C.
Learn More & Join Trial
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) PHASE4 It is increasingly recognized that although suppression of inflammation is ...
Show More Location
Hotung Centre for Musculoskeletal Diseases
Learn More & Join Trial
CD40L Antagonism in Rheumatoid Arthritis (RA) PHASE2 The primary objective is to determine if the addition of a 12-week course o...
Show More Location
University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center
Learn More & Join Trial
CHronic Nonbacterial Osteomyelitis International Registry N/A The objective of the study is to establish a prospective disease registry f...
Show More Location
Seattle Children's Hospital
Learn More & Join Trial